Document Detail


Similar potency of catechin and its enantiomers in alleviating 1-methyl-4-phenylpyridinium ion cytotoxicity in SH-SY5Y cells.
MedLine Citation:
PMID:  21827489     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
Objectives  Previously, the flavonoid (±)-catechin was shown to exert potent neuroprotective action in the mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease model. The purpose of this study was to investigate whether the different enantiomers of catechin ((+)-catechin, (-)-catechin and (±)-catechin, a 50 : 50 mixture of (+)-catechin and (-)-catechin) could protect SH-SY5Y cells against 1-methyl-4-phenylpyridinium ion (MPP(+) ) toxicity by decreasing the generation of oxygen free radicals. The inhibitive effect of (±)-catechin on JNK/c-Jun activation was investigated. Methods  The effects of (+)-catechin, (-)-catechin or (±)-catechin in protecting against MPP(+) toxicity were evaluated and compared in SH-SY5Y cells by testing the release of lactate dehydrogenase. The generation of reactive oxygen species (ROS) was measured by immunochemistry and the phosphorylation level of JNK/c-Jun was determined by Western blotting. Key findings  In SH-SY5Y cells, (+)-catechin, (-)-catechin or (±)-catechin reduced apoptosis induced by MPP(+) and decreased ROS generation caused by MPP(+) . Different enantiomers of catechin showed protective effects at similar potency. Moreover (±)-catechin decreased JNK/c-Jun phosphorylation which was increased by MPP(+) . Conclusions  Catechin and its two enantiomers could protect SH-SY5Y cells against MPP(+) cytotoxicity at a similar potency. Antioxidative stress and inhibition of the JNK/c-Jun signalling pathway might have been involved in the neuroprotective mechanisms of catechin against MPP(+) cytotoxicity in SH-SY5Y cells.
Authors:
Hao-Lan Ruan; Yi Yang; Xiao-Nan Zhu; Xue-Lan Wang; Ru-Zhu Chen
Related Documents :
2358049 - Behavioral correlates of theta-on and theta-off cells recorded from hippocampal formati...
2517459 - Control of forelimb muscle activity by populations of corticomotoneuronal and rubromoto...
3359189 - Electrophysiological effects of cholecystokinin octapeptide on identified rat nigrostri...
17294199 - Effects of beta-amyloid protein on m1 and m2 subtypes of muscarinic acetylcholine recep...
4136579 - Cell structure and function in the visual cortex of the cat.
21677139 - Cancer exosomes express cd39 and cd73, which suppress t cells through adenosine product...
2687179 - A novel maturation marker for human sertoli cells.
16860389 - Scarcity of lambda 1 b cells in mice with a single point mutation in c lambda 1 is due ...
8472019 - Viral transformation of baby hamster kidney cells affects the oxygen sensitivity of nit...
Publication Detail:
Type:  Journal Article     Date:  2011-06-21
Journal Detail:
Title:  The Journal of pharmacy and pharmacology     Volume:  63     ISSN:  0022-3573     ISO Abbreviation:  J. Pharm. Pharmacol.     Publication Date:  2011 Sep 
Date Detail:
Created Date:  2011-08-10     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0376363     Medline TA:  J Pharm Pharmacol     Country:  England    
Other Details:
Languages:  eng     Pagination:  1169-74     Citation Subset:  IM    
Copyright Information:
© 2011 The Authors. JPP © 2011 Royal Pharmaceutical Society.
Affiliation:
Guangdong Institute for Drug Control, Guangzhou, China Department of Pharmacology, Zhongshan School of Medicine, Sun Yat-Sen University, Guangzhou, China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Pharmacokinetics of caffeine in plasma and saliva, and the influence of caffeine abstinence on CYP1A...
Next Document:  Characterization of a unique dihydropyrimidinone, ethyl 4-(4'-heptanoyloxyphenyl)-6-methyl-3,4-dihyd...